Susquehanna Fundamental Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$1.17M Buy
2023
Q2
Sell
2023
Q1
$697K Hold
2022
Q4
$633K Sell
2022
Q3
$1.23M Buy
2022
Q1
$540K Buy